When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CARA - Cara's Korsuva successful in second late-stage study
Cara Therapeutics Inc.
Cara Therapeutics (NASDAQ:CARA) and licensee Vifor Fresenius Medical Care Renal Pharma announce positive results from a Phase 3 clinical trial, KALM-2, evaluating Korsuva (CR845/difelikefalin) Injection in hemodialysis patients with moderate-to-severe chronic kidney disease-associated pruritus (CKD-aP) (itchy skin), a condition affecting ~40% of dialysis patients.
More news on: Cara Therapeutics, Inc., Healthcare stocks news,